Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.49 Analyst target: $82.50 Upside: 2263.90%
Lexaria Bioscience Corp. The company is headquartered in Kelowna, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.